BPC 157 for Erectile Dysfunction: What the Evidence Actually Shows FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of BPC 157 Erectile Dysfunction: What the Evidence Shows and Practical Considerations Drew Timmermans, ND, RMSK There's a lot of confusion about the difference between BPC 157 arginate and acetate forms, so let's clear that up. The key distinction Instagram